Clinical trials on Dyslipidemias

  • CT-EU-00111148

    Exploring the Impact of Berberine and Monacolin K on Blood Sugar and Cholesterol

    Welcome to our clinical trial, which focuses on the Effect of the Association of Berberine Fitosoma® and Monacolin K MonaKoPure® on Glyco-metabolic Parameters in Dysglycemic and Dyslipidemic Patients. This study is designed to explore how effective a supplement called Berberol® K—which combines Berberine Fitosoma® and Monacolin K MonaKoPure®—is in managing blood sugar and cholesterol levels compared to a placebo.

    If you’re someone who has been dealing with fasting blood glucose levels that are a bit higher than normal (between 100 and 125 mg/dl) and also have high total cholesterol levels (≥ 200 mg/dl), this study might be of interest to you. The main goal here is to see if this supplement can help reduce LDL cholesterol—often referred to as ‘bad’ cholesterol—over a period of 12 months.

    This is a single-center, randomized, double-blind study, meaning participants will be randomly assigned to either the supplement group or a placebo group without knowing which one they’re receiving, to ensure the results are unbiased.

    By joining this study, you’ll be contributing to research that could potentially offer new insights into managing dysglycemia and dyslipidemia, conditions related to blood sugar and cholesterol levels, respectively. Your participation could help many people looking for alternative ways to manage these conditions.